Hjem / IKT -hub
Nettlesertag: IKT -hub
AALBORG EPAT HURTIGGUIDE DAYLIGHT
--:--
Calculating...
Daylight Duration
🌅 Sunrise
--:--
🌇 Sunset
--:--
LATEST IKT -HUB NEWS
- Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC
- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Receives Average Recommendation of "Buy" from Brokerages
- Inhibikase (IKT) Chart: Adds 1.70% to Close at $2.39 in Latest Trading; Trading Range: the Supplied Trading Band Runs From $2.27 to $2.51 for the Current Session - Fibonacci Extension
- Inhibikase Therapeutics (IKT) Slips 1.5% as Shares Test Support at $2.25 - Shakeout Pattern
- Inhibikase Therapeutics (IKT) Holds Steady at $2.41 as Shares Consolidate Between $2.29 Support and $2.53 Resistance - Reversal Setup Alerts
